Genta Incorporated
News from Genta Incorporated highlights the latest developments
Published in Lab Law Weekly, September 28th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Genta Incorporated.
Report 1: Genta Incorporated (NASDAQ:GNTAD) announced that it has received notice from the European Medicines Agency (EMEA) that the requested re-examination by the Committee for Medicinal Products for Human Use (CHMP) has reaffirmed a negative opinion for approval of the Company's marketing authorization application (MAA) for Genasense(R) (oblimersen). The MAA proposed the use of Genasense plus dacarbazine for treatment of patients with advanced melanoma. In its...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
Source: Lab Law Weekly (2007-09-28)
More Articles from Lab Law Weekly
- Association of Health Information Outsourcing Services
Association of Health Information Outsourcing Services Names New President - Bioengineering
Repligen Announces Settlement with ImClone In Erbitux Lawsuit - Biologics
Nabi Biopharmaceuticals Announces Sale of Nabi Biologics to Biotest AG - CML Healthcare
CML HealthCare Mourns Passing of Chairman Waldemar Zimmerman - Corporate Synergies Group, Inc.
Corporate Synergies Announces 2007 Fall Institute Schedule - Document Security Systems
Document Security Systems (Amex: DMC) Invites You to a Landmark Event - More from this issue of Lab Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
